Anatomic Stage III Breast Cancer AJCC v8 trials recruiting in Ohio

All Anatomic Stage III Breast Cancer AJCC v8 trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
  NCT07699991 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Ohio: Columbus
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Centerville, Cleveland, Columbus, Dayton
• Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
  NCT05677802 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Ohio: Cleveland, Columbus
• Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
  NCT06582615 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 65 Years · Sex: Female · Ohio: Columbus
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
  NCT05564377 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · Ohio: Athens, Avon, Beachwood, Belpre
• Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
  NCT05422794 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
  NCT07341503 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
  NCT05417308 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Female · Ohio: Columbus